Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2014
04/03/2014WO2013024059A9 Modified proteins and peptides
04/03/2014WO2012078761A3 Dimeric molecular complexes with free cysteine residues and conjugates thereof
04/03/2014WO2012065044A3 Treating bladder tumor cells using fibronectin attachment protein as a target
04/03/2014US20140094595 Protein Scaffolds for Antibody Mimics and Other Binding Proteins
04/03/2014US20140094594 Immunoaffinity Isolation of Modified Peptides From Complex Mixtures
04/03/2014US20140094417 Pseudomonas exotoxin a with less immunogenic t cell and/or b cell epitopes
04/03/2014US20140094392 Methods of generating libraries and uses thereof
04/03/2014US20140093959 Fc mutants
04/03/2014US20140093956 Modified Human Thymic Stromal Lymphopoietin
04/03/2014US20140093934 Substrates comprising switchable ferromagnetic nanoparticles
04/03/2014US20140093915 Il-18 receptor antigen binding proteins
04/03/2014US20140093892 Marker comprising anti-ck8/18 complex autoantibody and its use for diagnosing cancer
04/03/2014US20140093889 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
04/03/2014US20140093875 Mammalian cytokines; receptors; related reagents and methods
04/03/2014US20140093540 Immunogenic compositions and expression systems
04/03/2014US20140093529 Immunogenic composition
04/03/2014US20140093526 Preparation of Neutralizing Antibody to Human Herpesvirus 6 Glycoprotein Q1 and Analysis Thereof
04/03/2014US20140093521 Therapeutic dll4 binding proteins
04/03/2014US20140093516 Human antibodies that bind the p40 subunit of human il-12/il-23 and uses therefor
04/03/2014US20140093514 Magea3 binding antibodies
04/03/2014US20140093512 Pharmaceutical formulation comprising an antibody against p-selectin and a sugar selected from sucrose and trehalose
04/03/2014US20140093511 Optimization of antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof
04/03/2014US20140093509 Screening Method for the Identification of Agents Capable of Activating CD4+CD25+ Regulatory T-Cells Through Interactions with the HIV-1 GP120 Binding Site on CD4
04/03/2014US20140093508 Toll-Like 3 Receptor Antagonists
04/03/2014US20140093506 Anti-fungal-agents
04/03/2014US20140093504 Anti-Ricin Antibodies And Uses Thereof
04/03/2014US20140093502 Immunosuppressive Combination and Its Use in the Treatment or Prophylaxis of Insulin-producing Cell Graft Rejection
04/03/2014US20140093501 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus
04/03/2014US20140093500 Rsv specific binding molecule
04/03/2014US20140093497 Anti-cd40 antibodies and uses thereof
04/03/2014US20140093496 Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY
04/03/2014US20140093495 Novel modulators and methods of use
04/03/2014US20140093454 Human Monoclonal Antibodies Against CD20
04/02/2014EP2712930A2 Interferon alpha-induced pharmacodynamic markers
04/02/2014EP2712872A1 Bispecific antigen binding proteins
04/02/2014EP2712626A1 Passive immunisation against influenza, in particular H5N1
04/02/2014EP2634194A9 Anti-cdh3 antibody having high internalization capacity
04/02/2014CN103703372A Anti-human receptor-type protein tyrosine phosphatase sigma antibody
04/02/2014CN103703129A Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
04/02/2014CN103703027A Combination therapy with anti-CD19 antibody and purine analog
04/02/2014CN103703026A Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
04/02/2014CN103703025A Method of treating vision disorders
04/02/2014CN103703024A Cd3-binding molecules capable of binding to human and non-human cd3
04/02/2014CN103702721A IL-21 epitope and IL-21 ligands
04/02/2014CN103702685A Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
04/02/2014CN103695459A Plants with increased yield
04/02/2014CN103695376A Hybridoma cell strain secreting porcine circovirus type 2 Cap protein monoclonal antibody
04/02/2014CN103694356A Recombinant protein for detecting hog cholera virus, preparation method and application thereof
04/02/2014CN103694355A Recombinant antibody of anti-human cardiac troponin I as well as construction method and application thereof
04/02/2014CN103694354A Ciprofloxacin and clenbuterol bispecific fused antibody and application thereof
04/02/2014CN103694353A Monoclonal antibodies against claudin-18 for treatment of cancer
04/02/2014CN103694352A CD26 antibody and preparation method thereof
04/02/2014CN103694351A Inhibitors of receptor tyrosine kinases and methods of use thereof
04/02/2014CN103694350A Cross-species-specific cd3-epsilon binding domain
04/02/2014CN103694349A Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
04/02/2014CN103694348A Preparation and application method for treating swine viral diarrhea biological agent
04/02/2014CN103694347A Anti-human papilloma virus L1 protein antibody, and coding gene and application thereof
04/02/2014CN103694346A Anti-human papilloma virus L1 protein antibody, and coding gene and application thereof
04/02/2014CN103694345A Anti-human papilloma virus L1 protein antibody, and coding gene and application thereof
04/02/2014CN103694323A MntC recombinant protein of staphylococcus aureus and preparation method and application thereof
04/02/2014CN103694322A Staphylococcus aureus SpA5 mutant, as well as preparation method and application thereof
04/02/2014CN103694321A Staphylococcus aureus mSEB mutant and preparation method and application thereof
04/02/2014CN103694318A EV71 (Enterovirus 71) VP1 and RdRp (RNA dependent RNA polymerase) protein specific T cell epitope peptide as well as application thereof
04/02/2014CN103012585B Polyclonal antibody of integral membrane protein and preparation method thereof
04/02/2014CN102994454B Monoclonal antibody hybridoma cell strain of soybean lipoxygenase Lox3 as well as antibody and application of monoclonal antibody
04/02/2014CN102876637B Anti-GLIPR-2 monoclonal antibody hybridoma cell and anti-GLIPR-2 monoclonal antibody generated from same
04/02/2014CN102836430B Application of blocking antibody T5E3 to reversing of tumor multidrug resistance
04/02/2014CN102827272B Folate coupling antibody drug and preparation method and use thereof
04/02/2014CN102676459B Monoclonal antibody resistant to thermostable direct hemolysin of vibrio parahaemolyticus and preparation method of monoclonal antibody
04/02/2014CN102659693B 3-methylquinoxaline-2-carboxylic acid artificial antigen and antibody obtained by the 3-methylquinoxaline-2-carboxylic acid artificial antigen
04/02/2014CN102617589B Artificial antigen for aflatoxin M1 and antibody prepared by same
04/02/2014CN102585005B Monoclonal antibody and ELLSA (Enzyme Linked Immunosorbent Assay) method for detection of methyl-3-quinoxaline-2-carboxylic acid (MQCA), and kit
04/02/2014CN102471378B Readily isolated bispecific antibodies with native immuneoglobulin format
04/02/2014CN102224167B Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
04/02/2014CN102050878B Anti-human CD20 humanized antibody and preparation method and application thereof
04/02/2014CN101974088B Breast globin monoclonal antibody and application thereof in breast cancer diagnosis
04/02/2014CN101897969B Use of complement inhibitors in preparing medicines for preventing or treating tissure damage
04/02/2014CN101875694B Antibody of TNF (Tumor Necrosis Factor) alpha and application thereof
04/02/2014CN101595132B Use of thermostable biotin-binding protein and solid support having the protein bound thereto
04/01/2014US8686225 Monocot seed product comprising a human blood protein
04/01/2014US8686121 Compositions comprising soluble CD84 or anti-CD84 antibodies and methods for diagnosing and treating B-CLL
04/01/2014US8686120 DRG11-responsive (DRAGON) gene family
04/01/2014US8686119 Variants of humanized immunomodulatory monoclonal antibodies
04/01/2014US8685955 Neuroprotective iron chelators and pharmaceutical compositions comprising them
04/01/2014US8685932 Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases
04/01/2014US8685893 Phage display
04/01/2014US8685741 Methods for diagnosing irritable bowel syndrome
04/01/2014US8685725 Monoclonal antibodies with enhanced ADCC function
04/01/2014US8685722 Bovine adeno-associated viral (BAAV) vector and uses thereof
04/01/2014US8685662 Use of the α chain of brain spectrin and fragments thereof, for diagnosing cerebral diseases
04/01/2014US8685656 Methods for diagnosing and treating encephalitis or epilepsy
04/01/2014US8685651 Method for screening for an anti-CD4 antibody suitable for use in immunotherapy
04/01/2014US8685406 Compositions of and method of using heat shock protein peptides
04/01/2014US8685402 Neutralizing anti-influenza A virus antibodies and uses thereof
04/01/2014US8685399 PAX 5 monoclonal antibody
04/01/2014US8685397 Combination therapy for the treatment of ocular neovascular disorders
04/01/2014US8685396 Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin
04/01/2014US8685395 Methods of antagonizing signal transduction in dorsal root ganglion cells
04/01/2014US8685248 Purification of immunoglobulins
04/01/2014CA2583578C Chromatography ligand
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 1494